Pseudomonas aeruginosa hospital outbreak due to shared equiptment - Nursing Case Study
Pathophysiology
• Primary mechanism: Pseudomonas aeruginosa exploits shared hospital equipment as a reservoir, facilitated by its ability to form biofilms on surfaces, protecting it from disinfection and allowing persistent colonization and transmission to patients.
• Secondary mechanism: The bacterium's intrinsic resistance to many antibiotics and adaptive mutation capability lead to treatment challenges, increasing infection risk and severity, especially in immunocompromised patients.
• Key complication: Infections can progress to severe conditions like pneumonia or bloodstream infections, particularly in patients with weakened immune systems, leading to increased morbidity and hospital stay.
Patient Profile
Demographics:
52-year-old male, nurse
History:
• Key past medical history: Type 2 Diabetes, Hypertension
• Current medications: Metformin, Lisinopril
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Fever and shortness of breath
• Key symptoms: Cough with green sputum, fatigue, chest discomfort
• Vital signs: Temperature 101.3°F, Heart rate 110 bpm, Blood pressure 145/92 mmHg, Respiratory rate 24 breaths/min, Oxygen saturation 89% on room air
Section 1
As the patient's clinical team conducted an initial assessment, further evaluation revealed crackles in the lower lung fields upon auscultation, suggesting fluid accumulation and possible pneumonia. The patient's lab work showed leukocytosis with a white blood cell count of 15,000/mcL, indicating an inflammatory response. A chest X-ray displayed patchy infiltrates in the right lower lobe, supporting the suspicion of bacterial pneumonia secondary to Pseudomonas aeruginosa infection.
Given the patient's history of Type 2 Diabetes and the current presentation, the risk of complications such as sepsis or acute respiratory distress syndrome (ARDS) is heightened. The patient's glycemic control might be compromised due to the stress of infection, potentially exacerbating the inflammatory response and complicating recovery. Immediate interventions included initiating supplemental oxygen therapy to maintain oxygen saturation above 92%, starting empirical antibiotic therapy with a combination of aminoglycosides and cephalosporins, considering the patient's penicillin allergy, and close monitoring of vital signs and oxygenation status.
However, the adaptive resistance of Pseudomonas aeruginosa presents a significant challenge. The healthcare team must await culture and sensitivity results to tailor antibiotic therapy effectively. The patient's condition necessitates vigilant monitoring for signs of clinical deterioration, such as increasing respiratory distress or hemodynamic instability, which could indicate the progression to severe pneumonia or bacteremia. This scenario not only highlights the importance of infection control practices in preventing hospital-acquired infections but also underscores the need for prompt, targeted treatment strategies to mitigate the risk of severe complications in vulnerable patients.
Section 2
New Complications:
Over the next 48 hours, the patient's condition showed signs of deterioration despite the initial interventions. The patient began exhibiting increased respiratory rate, now at 28 breaths per minute, and a new onset of mild confusion, suggesting possible hypoxemia or sepsis-related encephalopathy. Oxygen saturation levels fluctuated, occasionally dipping to 89% on supplemental oxygen, prompting the clinical team to increase the oxygen flow. The patient's blood pressure dropped to 95/60 mmHg, raising concerns about potential septic shock. Repeat laboratory tests revealed a further increase in white blood cell count to 18,500/mcL, and a C-reactive protein level of 150 mg/L, indicative of an escalating inflammatory process. Blood cultures confirmed Pseudomonas aeruginosa, and sensitivity results suggested resistance to the initial empirical antibiotics, necessitating a change in the antibiotic regimen to include a carbapenem, specifically meropenem.
The patient's glycemic control became increasingly difficult to manage, with blood glucose levels rising to 250 mg/dL, despite adjustments in insulin therapy. This hyperglycemia complicated the inflammatory response, potentially worsening the patient's immune function. The clinical team recognized the need for a multidisciplinary approach to manage the patient's complex needs, involving endocrinology to optimize glycemic control and infectious disease specialists to refine antibiotic management. The team also deliberated the potential need for mechanical ventilation should the patient's respiratory status decline further.
The unfolding situation necessitated swift clinical reasoning to prioritize interventions aimed at stabilizing the patient's hemodynamics while addressing the infection aggressively. The nursing staff focused on close monitoring for any further changes in mental status or respiratory effort, as well as continuous reassessment of vital signs and laboratory results. The emerging complications underscored the critical importance of dynamic and responsive care plans to prevent progression to severe sepsis or ARDS, particularly in a patient with underlying chronic conditions such as diabetes.
Section 3
New Diagnostic Results:
As the clinical team continued to address the patient's deteriorating condition, further diagnostic tests were ordered to gain a clearer understanding of the underlying issues. A chest X-ray revealed diffuse bilateral infiltrates, suggestive of developing acute respiratory distress syndrome (ARDS), likely secondary to the severe Pseudomonas infection. This finding corroborated the clinical signs of worsening respiratory function and necessitated an immediate review of the patient's respiratory support needs. Arterial blood gas analysis showed a pH of 7.32, PaCO2 of 50 mmHg, and PaO2 of 60 mmHg on a high-flow oxygen system, indicating respiratory acidosis and significant hypoxemia, further validating the suspicion of ARDS.
Additionally, a repeat renal function panel indicated a rise in serum creatinine to 2.1 mg/dL and a blood urea nitrogen of 35 mg/dL, suggestive of acute kidney injury (AKI), potentially due to sepsis-induced hypoperfusion or antibiotic nephrotoxicity. This renal impairment posed a challenge in managing fluid balance, especially given the patient's hypotensive state and the risk of fluid overload exacerbating ARDS. The nephrology team was consulted to assess the need for renal replacement therapy and to carefully balance the patient's fluid and electrolyte status.
These new diagnostic results prompted the clinical team to escalate care, including discussions about transferring the patient to the intensive care unit for closer monitoring and potential initiation of mechanical ventilation. The multidisciplinary team, including pulmonologists and nephrologists, worked together to refine the care plan, focusing on optimizing respiratory support, preventing further organ dysfunction, and tailoring antibiotic therapy to combat the resistant Pseudomonas strain effectively. This collaborative approach aimed to stabilize the patient's condition and prevent further progression of complications, highlighting the importance of cohesive interdisciplinary management in complex clinical scenarios.
Section 4
New Complications
As the patient's condition continued to be closely monitored, new complications emerged. The patient's blood pressure, which had been maintained with vasopressors, began to fluctuate more unpredictably. Despite aggressive fluid resuscitation and vasopressor support, the patient's mean arterial pressure dropped to 55 mmHg, indicating worsening shock. This hemodynamic instability raised concerns about potential septic shock, exacerbated by the ongoing Pseudomonas infection. In response, the team initiated a norepinephrine infusion to stabilize the blood pressure and discussed the possibility of adding vasopressin if further support was needed.
Concurrent with these developments, the patient's neurological status showed signs of deterioration. Initially, the patient was alert and oriented, but now there was a notable decline in mental status, with the patient becoming increasingly lethargic and confused. A bedside assessment indicated that the Glasgow Coma Scale score had dropped to 10, suggesting significant changes in neurological function. This alteration in mental status prompted a swift assessment for potential causes, such as worsening hypoxemia, hypotension, or metabolic disturbances related to the ongoing renal impairment and infection. The team considered the need for a CT scan of the brain to rule out central nervous system complications and reviewed the current medication regimen for potential sedative effects.
These emerging complications underscored the complexity of the patient's condition, highlighting the need for continuous reassessment and adaptation of the treatment plan. The interdisciplinary team, including intensivists and infectious disease specialists, remained vigilant, prioritizing the stabilization of hemodynamics and addressing potential causes of the altered mental status. As the patient's journey unfolded, the focus remained on preventing further deterioration and exploring all avenues to combat the resistant infection, stabilize organ function, and ensure the best possible outcomes. This adaptive approach emphasized the critical role of dynamic clinical reasoning in managing complex and evolving clinical scenarios.
Section 5
As the team continued to monitor the patient's condition, new diagnostic results provided additional insights into the evolving clinical picture. Blood cultures confirmed the presence of Pseudomonas aeruginosa, reinforcing the need for aggressive antimicrobial therapy. Sensitivity testing revealed resistance to several first-line antibiotics, necessitating a change in the antimicrobial regimen to include ceftazidime and amikacin, two antibiotics with efficacy against this resistant strain. In addition to the infection, laboratory tests revealed worsening renal function, with creatinine levels rising to 3.5 mg/dL and a significant drop in urine output, indicating acute kidney injury likely secondary to both septic shock and nephrotoxic medications.
The patient's hemodynamic status remained a top priority. Despite norepinephrine infusion, blood pressure readings fluctuated, with systolic pressures dipping into the 80s mmHg. The interdisciplinary team decided to introduce low-dose vasopressin to enhance vasopressor support and improve vascular tone. Meanwhile, the patient's lactate levels were elevated at 4.5 mmol/L, suggesting persistent tissue hypoperfusion. This prompted a review of the fluid management strategy, balancing the need for volume expansion against the risk of fluid overload, particularly given the compromised renal function and the potential for pulmonary edema.
These findings necessitated a dynamic reassessment of the therapeutic plan, focusing on tailoring antimicrobial therapy to combat the resistant Pseudomonas strain while optimizing hemodynamic support to prevent further organ dysfunction. The team also discussed the potential need for renal replacement therapy if the patient's renal function continued to decline. As the case unfolded, the emphasis remained on meticulous monitoring and timely intervention, leveraging clinical reasoning to navigate the complexities of a critical care scenario complicated by infection, shock, and multi-organ involvement. The next steps in the patient's journey would involve close monitoring of response to the new treatment regimen and ongoing evaluation of organ function and hemodynamic stability.